Generics gain ground, yet HCPs still favor branded drugs: GlobalData
GlobalData’s survey “Generic Drugs - Physician Perspective” uncovered that if cost was not the primary factor, overall close to 40…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Category
Market
Bharat Biotech, Bilthoven Biologicals B.V. partner to produce and supply oral polio vaccines
BBIL will procure drug substances for the production of oral polio vaccines to be supplied within India and globally
WHO INN approves ‘Usnoflast’ as recommended name for ZYIL1 from Zydus
Usnoflast (ZYIL1) is a novel oral small molecule NLRP3 inhibitor discovered at Zydus. Studies have demonstrated that ZYIL1 is…
Bora Pharmaceuticals acquires Upsher-Smith
The acquisition expands Taiwan-based Bora’s North American footprint with its first US manufacturing site
Active cooperation among APAC pharma companies gaining traction: GlobalData
According to GlobalData’s Pharmaceutical Intelligence Center, from 2019 to 2023, 673 deals (strategic alliances) occurred among…
Jubilant Ingrevia commissions new facility for Diketene and derivatives
The newly commissioned facility adds additional capacity of ~2,000 TPA to produce high-value esters
Caplin Steriles gets USFDA approval for Ketorolac Tromethamine Ophthalmic Solution
It is a nonsteroidal, anti-inflammatory indicated for the treatment of inflammation following cataract surgery and for the…
Credit profile of Indian pharma cos to remain healthy in FY2025 despite moderation in revenue…
Revenue growth to moderate to 8-10 per cent in FY2025, post a healthy 13-14 per cent YoY expansion in FY2024
Veeda Clinical Research acquires Heads, a European CRO
Veeda expands its reach to major geographies and adds capabilities of late-stage clinical trial execution with strong focus on…
AstraZeneca India gets dual CDSCO approval for Trastuzumab deruxtecan
Additional indications for treatment of HER2 low breast cancer and HER2 positive gastric / gastro-oesophageal cancer
Sanofi signs distribution pact with Cipla for CNS portfolio in India
Cipla will be responsible for the distribution of Sanofi India’s six CNS brands including Frisium
Merck Life Science signs MoU with Amity University, UP, Noida Campus for academic and research…
Under this MoU, 'practical and industry oriented certificate courses' focusing on advanced instrumentation will be offered to the…
Pharmazz, Dr Reddy’s enter licensing pact to market Centhaquine in India
Centhaquine is a resuscitative agent to treat hypovolemic shock by increasing stroke volume and cardiac output due to an increase…
Vaccines in late-stage development hold promise in tackling disease burden: GlobalData
According to GlobalData, there are 11 vaccines in late-stage development* for TB globally
vriddhi 2024: The Indian pharma industry comes together to deliberate on glorious future
Mehul Shah, Honorary General Secretary, Indian Drug Manufacturers' Association (IDMA) and Managing Director of Encube Ethicals…
Pfizer’s Braftovi to command 42 per cent share of BRAF inhibitors melanoma market by 2028:…
GlobalData’s patient-based forecast reveals that the BRAF inhibitor market for melanoma will reach a key milestone by 2028, with…
STEERWorld announces its Strategic Advisory Board
Naiyya Saggi, Vipul Parekh and Sachin Oswal will bring diverse perspectives and strategic guidance as Steer enters its next phase…
Dr Reddy’s launches Versavo (bevacizumab) in the UK
It is indicated for the treatment of several types of cancers
DP World expands its global freight forwarding network
Including 16 plus locations in India in major metros and tier I cities
Sun Pharma gets approval for Winlevi in Australia
Winlevi is indicated for the topical treatment of acne vulgaris in patients 12 years of age and older